Patent · US Active

Use of oligouronates for treating mucus hyperviscosity

US8754063B2 · kind B2 · utility

0Cited by

13References

12Claims

0Family size

Assignee

NTNU TECHNOLOGY TRANSFER AS · NO

Inventors

Catherine Taylor · Waterloo, CA
Kurt Ingar Draget · Trondheim, NO
Olav Asmund Smidsrod · Trondheim, NO

Key dates

Filing date	Oct 6, 2006
Grant date	Jun 17, 2014
Priority date	—
Expiry date	Dec 14, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method includes application to a mucosal surface in the tract in the subject of an effective amount of a physiologically tolerable oligouronate. Related compositions containing physiologically tolerable oligouronates are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.